{"&cites=8449425975912964334&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"Everolimus for advanced pancreatic neuroendocrine tumors","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa1009290","authors":["JC Yao","JC Yao MH Shah","JC Yao MH Shah T Ito","JC Yao MH Shah T Ito CL Bohas…"],"year":2011,"numCitations":2562,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa1009290","citationUrl":"http://scholar.google.com/scholar?cites=3224378860632949803&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:K0ROgX1LvywJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3224378860632949803&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc","p":1,"exp":1596898398212},{"title":"Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial","url":"http://s-space.snu.ac.kr/handle/10371/77398","authors":["CN Sternberg","CN Sternberg ID Davis","CN Sternberg ID Davis J Mardiak…"],"year":2010,"numCitations":2448,"pdf":"http://s-space.snu.ac.kr/bitstream/10371/77398/1/Sternberg-2010-Pazopanib%20in%20Locally.pdf","citationUrl":"http://scholar.google.com/scholar?cites=17868513553253356300&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:DFPrvWe2-fcJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17868513553253356300&hl=en&as_sdt=2005&sciodt=0,5","publication":"s-space.snu.ac.kr"},{"title":"Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial","url":"https://www.sciencedirect.com/science/article/pii/S0140673611616139","authors":["BI Rini","BI Rini B Escudier","BI Rini B Escudier P Tomczak","BI Rini B Escudier P Tomczak A Kaprin","BI Rini B Escudier P Tomczak A Kaprin C Szczylik…"],"year":2011,"numCitations":1695,"citationUrl":"http://scholar.google.com/scholar?cites=3547505814206124423&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:h5FjFr5FOzEJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3547505814206124423&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","url":"https://www.nature.com/articles/nature12222","authors":["Cancer Genome Atlas Research Network"],"year":2013,"numCitations":1643,"pdf":"https://www.nature.com/articles/nature12222","citationUrl":"http://scholar.google.com/scholar?cites=17309623389709980314&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:mtJ0O8MiOPAJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17309623389709980314&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com"},{"title":"EAU guidelines on renal cell carcinoma: the 2010 update","url":"https://www.sciencedirect.com/science/article/pii/S0302283810005919","authors":["B Ljungberg","B Ljungberg NC Cowan","B Ljungberg NC Cowan DC Hanbury","B Ljungberg NC Cowan DC Hanbury M Hora…"],"year":2010,"numCitations":1557,"pdf":"http://www.aamed.eco.br/imagens/pdf/EAU-Guidelines-on-Renal-Cell-Carcinoma-the-2010-Update.pdf","citationUrl":"http://scholar.google.com/scholar?cites=13647781770707630156&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:THgUHzapZr0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13647781770707630156&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Renal cell carcinoma","url":"https://www.sciencedirect.com/science/article/pii/S0140673609602294","authors":["BI Rini","BI Rini SC Campbell","BI Rini SC Campbell B Escudier"],"year":2009,"numCitations":1387,"pdf":"https://oncologypro.esmo.org/content/download/233726/3944876/file/2019-ESMO-ESO-Course-Valencia-Renal-Cancer-Christoph-Oing.pdf","citationUrl":"http://scholar.google.com/scholar?cites=807962691249077211&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:23urc8l1NgsJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=807962691249077211&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors","url":"https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.25219","authors":["RJ Motzer","RJ Motzer B Escudier","RJ Motzer B Escudier S Oudard","RJ Motzer B Escudier S Oudard TE Hutson","RJ Motzer B Escudier S Oudard TE Hutson C Porta…"],"year":2010,"numCitations":1291,"pdf":"https://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.25219","citationUrl":"http://scholar.google.com/scholar?cites=10740650070320312012&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:zG43IlV0DpUJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10740650070320312012&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"},{"title":"Targeting metabolic transformation for cancer therapy","url":"https://www.nature.com/articles/nrc2817/","authors":["DA Tennant","DA Tennant RV Durán","DA Tennant RV Durán E Gottlieb"],"year":2010,"numCitations":1008,"pdf":"https://www.researchgate.net/profile/Daniel_Tennant/publication/42345654_Tennant_DA_Duran_RV_Gottlieb_E_Targeting_metabolic_transformation_for_cancer_therapy_Nat_Rev_Cancer_10_267-277/links/00463526e8741191b7000000.pdf","citationUrl":"http://scholar.google.com/scholar?cites=6904997644786816412&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:nFVtEMZ6018J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6904997644786816412&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com"},{"title":"Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival","url":"http://mauriciolema.webhost4life.com/rolmm/files/AVOREN.pdf","authors":["B Escudier","B Escudier J Bellmunt","B Escudier J Bellmunt S Négrier…"],"year":2010,"numCitations":864,"pdf":"http://mauriciolema.webhost4life.com/rolmm/files/AVOREN.pdf","citationUrl":"http://scholar.google.com/scholar?cites=18293771856512896465&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:0U19NZSI4P0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=18293771856512896465&hl=en&as_sdt=2005&sciodt=0,5","publication":"mauriciolema.webhost4life.com"},{"title":"Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB …","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc2860433/","authors":["BI Rini","BI Rini S Halabi","BI Rini S Halabi JE Rosenberg…"],"year":2010,"numCitations":862,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc2860433/","citationUrl":"http://scholar.google.com/scholar?cites=3956532382067211975&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:xz5yJz1t6DYJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3956532382067211975&hl=en&as_sdt=2005&sciodt=0,5","publication":"ncbi.nlm.nih.gov"}]}